CUTISS AG logo

CUTISS AG

FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company

61 employees · est. 2017 · Schlieren, Switzerland

VS
Fesarius Therapeutics logo

Fesarius Therapeutics

A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.

8 employees · est. 2015 · United States

Fesarius Therapeutics is the older company (2017 vs 2015); CUTISS AG is the larger of the two.

Side-by-Side Comparison

CUTISS AG Fesarius Therapeutics
Founded
2017 2015 older
Headquarters
Schlieren, Switzerland United States
Employees
61 larger 8
Industry
Biotechnology, Health Care, Wellness Beauty Biotechnology, Manufacturing
Funding Stage
Series C Grant
Total Funding
$109.66M $2.63M
Funding Rounds
9 3
Services
Development of denovoSkin™, Automated Living Skin Production, Scalable Bioengineering Solutions, Clinical Manufacturing Not tracked yet
Target Customers
Burn Patients, Healthcare Providers in Reconstructive Surgery, Aesthetic Surgery Centers, Regenerative Medicine Researchers, Industrial Partners for Bioengineering Not tracked yet
Taxonomy
Skin Tissue Therapy, Personalized Medicine, Bioengineering, TechBio, Automated Manufacturing, Regenerative Medicine, Clinical Trials, Orphan Drug Designation, Burn Treatment, Reconstructive Surgery, Aesthetic Procedures, Scalable Healthcare Solutions, Regulatory Approvals, Skin Graft Technology, Bio-technopark Zurich Regenerative Medicine, Tissue Engineering, Dermal Regeneration, Wound Healing, Material Science, Skin Replacement, Dermatology, Start-up, Technology Innovation, Bioregenerative Medicine, Weill Cornell Medicine, Surgical Innovation, Research And Development
Website
cutiss.swiss fesariustherapeutics.com
CUTISS AG logo

About CUTISS AG

CUTISS AG, a pioneering force in BIOTECHNOLOGY and HEALTH CARE, is redefining skin surgery with its innovative skin tissue therapeutics. Established in 2017 as a spin-off from the University of Zurich (UZH) and University Children’s Hospital, this Swiss firm is headquartered at the Bio-Technopark in...

Fesarius Therapeutics logo

About Fesarius Therapeutics

FesariusTherapeutics is a cutting-edge NY-based biotech start-up founded in 2015 with a mission to revolutionize the world of regenerative medicine. Their slogan, "A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine," reflects their dedication to...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at CUTISS AG and Fesarius Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at CUTISS AG and Fesarius Therapeutics — by email.

Frequently Asked Questions

CUTISS AG — FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company. Fesarius Therapeutics — A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CUTISS AG has raised $109.66M while Fesarius Therapeutics has raised $2.63M.
CUTISS AG and Fesarius Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CUTISS AG with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy